Eros International (EROS) Stock Rating Lowered by Zacks Investment Research

Share on StockTwits

Zacks Investment Research cut shares of Eros International (NYSE:EROS) from a hold rating to a sell rating in a research report report published on Friday, August 24th.

According to Zacks, “Eros International Plc co-produces, acquires and distributes Indian language film content across multiple formats globally, including theatrical, television and digital channels. It distributes Indian-made films, known as Bollywood movies, in the United Kingdom, United States, Australia, the United Arab Emirates, and India. The Company releases Indian films that are subtitled or dubbed in local languages to Germany, Poland, Russia, Indonesia, Malaysia, Taiwan, Japan, South Korea, China and Arabic speaking countries. Eros International Plc is based in Douglas, the United Kingdom. “

Several other equities research analysts have also weighed in on the company. Citigroup initiated coverage on Eros International in a research report on Tuesday, August 14th. They set a buy rating and a $16.00 price target on the stock. ValuEngine raised Eros International from a hold rating to a buy rating in a report on Tuesday, July 31st. Finally, Wells Fargo & Co upped their price target on Eros International from $15.00 to $17.00 and gave the company an outperform rating in a report on Thursday, June 28th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $16.67.

Eros International stock traded up $0.10 during trading hours on Friday, reaching $12.75. The company had a trading volume of 253,006 shares, compared to its average volume of 409,121. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.25 and a quick ratio of 1.25. The stock has a market capitalization of $715.98 million, a P/E ratio of -141.67 and a beta of 0.66. Eros International has a 12-month low of $9.20 and a 12-month high of $16.90.

Eros International (NYSE:EROS) last posted its earnings results on Wednesday, June 27th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.15 by ($0.10). Eros International had a negative net margin of 13.52% and a positive return on equity of 1.31%. The business had revenue of $71.93 million for the quarter, compared to analysts’ expectations of $71.65 million.

A number of institutional investors and hedge funds have recently modified their holdings of the business. California State Teachers Retirement System grew its position in shares of Eros International by 18.0% during the first quarter. California State Teachers Retirement System now owns 46,754 shares of the company’s stock worth $510,000 after purchasing an additional 7,133 shares in the last quarter. Russell Investments Group Ltd. purchased a new stake in shares of Eros International during the first quarter worth about $540,000. Finally, Bank of New York Mellon Corp grew its position in shares of Eros International by 10.1% during the second quarter. Bank of New York Mellon Corp now owns 92,078 shares of the company’s stock worth $1,197,000 after purchasing an additional 8,414 shares in the last quarter. Institutional investors and hedge funds own 61.34% of the company’s stock.

Eros International Company Profile

Eros International Plc, together with its subsidiaries, co-produces, acquires, and distributes Indian films in various formats worldwide. The company distributes its film content through various distribution channels, including theatrical, which includes multiplex chains and stand-alone theaters; television syndication that comprises satellite television broadcasting, cable television, and terrestrial television; and digital and ancillary, such as Internet protocol television, video on demand, music, inflight entertainment, home video, and Internet channels, as well as Eros Now online entertainment service.

Further Reading: What is the NASDAQ?

Get a free copy of the Zacks research report on Eros International (EROS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Eros International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eros International and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.